| Literature DB >> 23441189 |
Yongsheng Hu1, Haiping Xu, Zhenhui Li, Xuejuan Zheng, Xinzheng Jia, Qinghua Nie, Xiquan Zhang.
Abstract
INTRODUCTION: Growth traits are important in poultry production, however, little is known for its regulatory mechanism at epigenetic level. Therefore, in this study, we aim to compare DNA methylation profiles between fast- and slow-growing broilers in order to identify candidate genes for chicken growth. Methylated DNA immunoprecipitation-sequencing (MeDIP-seq) was used to investigate the genome-wide DNA methylation pattern in high and low tails of Recessive White Rock (WRR(h); WRR(l)) and that of Xinhua Chickens (XH(h); XH(l)) at 7 weeks of age. The results showed that the average methylation density was the lowest in CGIs followed by promoters. Within the gene body, the methylation density of introns was higher than that of UTRs and exons. Moreover, different methylation levels were observed in different repeat types with the highest in LINE/CR1. Methylated CGIs were prominently distributed in the intergenic regions and were enriched in the size ranging 200-300 bp. In total 13,294 methylated genes were found in four samples, including 4,085 differentially methylated genes of WRR(h) Vs. WRR(l), 5,599 of XH(h) Vs. XH(l), 4,204 of WRR(h) Vs. XH(h), as well as 7,301 of WRR(l) Vs. XH(l). Moreover, 132 differentially methylated genes related to growth and metabolism were observed in both inner contrasts (WRR(h) Vs. WRR(l) and XH(h) Vs. XH(l)), whereas 129 differentially methylated genes related to growth and metabolism were found in both across-breed contrasts (WRR(h) Vs. XH(h) and WRR(l) Vs. XH(l)). Further analysis showed that overall 75 genes exhibited altered DNA methylation in all four contrasts, which included some well-known growth factors of IGF1R, FGF12, FGF14, FGF18, FGFR2, and FGFR3. In addition, we validate the MeDIP-seq results by bisulfite sequencing in some regions.Entities:
Mesh:
Year: 2013 PMID: 23441189 PMCID: PMC3575439 DOI: 10.1371/journal.pone.0056411
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
The information of primers for bisulfite sequencing.
| Primers | Primer sequence (5′→3′) | Length | AT | Location |
| PM1 | F: | 415 | 62 | chr9: 6199130–6199544 |
| R: | ||||
| PM2 | F:TTGATTGTAGTGGATTTGGATT | 354 | 62 | chr6: 10360074–10360427 |
| R: | ||||
| PM3 | F: | 357 | 62 | chr6: 1036407–10360763 |
| R: | ||||
| PM4 | F: | 346 | 62 | chrUn_ Random: 45286930–45287275 |
| R: | ||||
| PM5 | F: | 433 | 62 | chrUn_Random: 45287248–45287680 |
| R: |
referred to the product length.
indicated annealing temperature.
indicated the PCR amplified locations in chicken chromosomes.
Data generated by MeDIP-seq.
| Sample | Total numberof reads | Total MappedReads | Total Unique MappedReads | Percentage of mappedreads in total reads | Percentage of unique mapped reads |
| WRRh | 36,734,694 | 23,877,624 | 13,087,223 | 65.00% | 35.63% |
| WRRl | 33,399,566 | 21,861,843 | 12,287,910 | 65.46% | 36.79% |
| XHh | 36,734,694 | 23,472,733 | 12,875,987 | 63.90% | 35.05% |
| XHl | 36,734,694 | 23,897,397 | 13,728,925 | 65.05% | 37.37% |
WRRh, WRRl, XHh, and XHl indicated the group of Recessive White Rock with high body weight, Recessive White Rock with low body weight, Xinhua Chickens with high body weight, and Xinhua Chickens with low body weight, respectively.
Figure 1Genomic distribution of the uniquely mapped reads.
All uniquely mapped reads were classified into four types: reads uniquely mapped to CpG islands (dark blue), genes bodies (green), repeats (red), others (light blue). The percentage for each class was given at the top of each graph. WRRh, WRRl, XHh, and XHl indicated the group of Recessive White Rock with high body weight, Recessive White Rock with low body weight, Xinhua Chickens with high body weight, and Xinhua Chickens with low body weight, respectively.
Figure 2The validation of MeDIP-seq data by bisulfite sequencing.
One region with high methylation obtained from MeDIP-Seq data was selected and its methylation pattern was assessed by bisulfite sequencing. Each line corresponded to a single strand of DNA and each circle represented a single CpG dinucleotide. Filled circles and open circles indicated methylated sites and unmethylated sites, respectively.
The peak distribution in different components of the chicken genome.
| Sample | Total peak number | Promoter | 5′UTR | Exon | Intron | 3′UTR | Intergenic | CGI | Repeats |
| WRRh | 44945 | 3838 | 608 | 10633 | 17689 | 1362 | 29390 | 4406 | 7493 |
| WRRl | 44832 | 3582 | 537 | 10388 | 17593 | 1268 | 31712 | 4020 | 6239 |
| XHh | 42747 | 3930 | 554 | 9970 | 16510 | 1278 | 27270 | 4412 | 6995 |
| XHl | 53821 | 4185 | 740 | 12781 | 20746 | 1563 | 36962 | 5084 | 7239 |
WRRh, WRRl, XHh, and XHl indicated the group of Recessive White Rock with high body weight, Recessive White Rock with low body weight, Xinhua Chickens with high body weight, and Xinhua Chickens with low body weight, respectively.
Total peak number indicated the number of methylated peaks in the whole genome in each sample.
Figure 3Methylation distribution in different genomic regions.
Methylation density within promoter, gene body and intergenic regions was calculated with the ratio of methylated peaks in a particular component to the total area of that region.
The distribution of methylated peaks in different repeat types.
| Repeat type | WRRh
| WRRl
| XHh
| XHl
|
| DNA | 2.19 | 2.85 | 2.37 | 3.38 |
| DNA/TcMar | 0.87 | 1.09 | 0.81 | 1.22 |
| LINE/CR1 | 44.57 | 43.23 | 41.39 | 48.78 |
| Low_complexity | 6.7 | 8.74 | 9.96 | 6.87 |
| LTR | 0.39 | 0.38 | 0.31 | 0.41 |
| LTR/ERV1 | 3.88 | 2.48 | 2.56 | 2.69 |
| LTR/ERVK | 4.55 | 3.27 | 3.65 | 3.18 |
| LTR/ERVL | 21.83 | 21.16 | 20.24 | 19.34 |
| rRNA | 0.08 | 0.08 | 0.09 | 0.12 |
| Satellite | 2.72 | 3.14 | 4.15 | 3.34 |
| Satellite/macro | 2.88 | 1.28 | 0.96 | 1.41 |
| Satellite/W-chromosome | 1.07 | 1.23 | 1.16 | 1.11 |
| Simple_repeat | 7.79 | 10.34 | 11.68 | 7.39 |
| SINE | 0.19 | 0.3 | 0.29 | 0.43 |
| tRNA | 0.05 | 0.1 | 0.07 | 0.07 |
| Unknown | 0.23 | 0.32 | 0.31 | 0.26 |
WRRh, WRRl, XHh, and XHl indicated the group of Recessive White Rock with high body weight, Recessive White Rock with low body weight, Xinhua Chickens with high body weight, and Xinhua Chickens with low body weight, respectively.
Summary of methylated CGIs in the group of WRRh, WRRl, XHh, and XHl.
| Sample | 5′UTR | 3′UTR | Exon | Intron | Intergenic | Total methylated CGIs | Total CGIs | Methylated (%) |
| WRRh | 54 | 88 | 1154 | 844 | 3195 | 4406 | 33915 | 13.0 |
| WRRl | 49 | 80 | 1044 | 750 | 2853 | 4020 | 33915 | 11.9 |
| XHh | 56 | 96 | 1158 | 838 | 3208 | 4412 | 33915 | 13.0 |
| XHl | 66 | 101 | 1322 | 970 | 3687 | 5084 | 33915 | 15.0 |
WRRh, WRRl, XHh, and XHl indicated the group of Recessive White Rock with high body weight, Recessive White Rock with low body weight, Xinhua Chickens with high body weight, and Xinhua Chickens with low body weight, respectively.
Figure 4Genomic distribution of methylated and unmethylated CpG islands.
We subdivided CpG islands into methylated and unmethylated islands and then categorized them into different bins according to their sizes. A. Genomic distribution of methylated CpG islands. B. Genomic distribution of unmethylated CpG islands. The number of CpG islands in a particular bin was calculated in different regions and subsequently it was normalized by the total number of CpG islands in that bin. Here the genomic region 2 kb upstream and downstream of the transcription start site was regarded as promoter. A, B, C, and D indicated the group of Recessive White Rock with high body weight (WRRh), Recessive White Rock with low body weight (WRRl), Xinhua Chickens with high body weight (XHh), and Xinhua Chickens with low body weight (XHl), respectively.
Figure 5Methylated genes among four groups of WRRh, WRRl, XHh, and XHl.
The methylated gene number was given at the top of each figure section. WRRh, WRRl, XHh, and XHl indicated the group of Recessive White Rock with high body weight, Recessive White Rock with low body weight, Xinhua Chickens with high body weight, and Xinhua Chickens with low body weight, respectively.
Figure 6Functional classification of the whole methylated genes.
(A) GO: Biological process. (B) Cellular component. (C) GO: Molecular function.
Figure 7Differentially methylated genes unique or shared among four contrasts of WRRh Vs. WRRl, XHh Vs. XHl, WRRh Vs. XHh, and WRRl Vs. XHl.
The number of differently methylated genes in each comparison was given at the top of each section of figures. WRRh Vs. WRRl indicated the comparison between the two-tail samples of Recessive White Rock. XHh Vs. XHl indicated the comparison between the two-tail samples of Xinhua Chickens. WRRh Vs. XHh indicated the comparison between the groups of Recessive White Rock and Xinhua Chickens with high body weight. WRRl Vs. XHl indicated the comparison between the groups of Recessive White Rock and Xinhua Chickens with low body weight.
Numbers of differentially methylated genes for each contrast in different gene regions.
| Contrast | Upstream 2 k | 5′UTR | Exon | Intron | 3′UTR | Downstream 2 k |
| WRRh Vs. WRRl (up) | 108 | 20 | 474 | 1135 | 32 | 89 |
| WRRh Vs. WRRl (down) | 367 | 71 | 1447 | 2396 | 160 | 303 |
| XHh Vs. XHl (up) | 700 | 179 | 2665 | 3373 | 341 | 578 |
| XHh Vs. XHl (down) | 100 | 12 | 449 | 1198 | 33 | 84 |
| WRRh Vs. XHh (up) | 192 | 48 | 739 | 1571 | 57 | 161 |
| WRRh Vs. XHh (down) | 291 | 65 | 1187 | 2127 | 132 | 257 |
| WRRl Vs. XHl (up) | 1138 | 349 | 3830 | 4587 | 585 | 996 |
| WRRl Vs. XHl (down) | 115 | 16 | 468 | 1276 | 33 | 107 |
WRRh, WRRl, XHh, and XHl indicated the group of Recessive White Rock with high body weight, Recessive White Rock with low body weight, Xinhua Chickens with high body weight, and Xinhua Chickens with low body weight, respectively. For each contrast, up meant that there were greater peaks in the second group than the first group within the same region, whereas down meant there were greater peaks in the first group than the second group (p value<0.01).
KEGG pathways in which the common differentially methylated genes of WRRh Vs. WRRl and XHh Vs. XHl enriched.
| No. | Pathways | P value | Benjiamini |
| 1 | Focal adhesion | 4.60E−05 | 5.90E−03 |
| 2 | Wnt signaling pathway | 2.30E−04 | 1.50E−02 |
| 3 | MAPK signaling pathway | 2.80E−04 | 1.20E−02 |
| 4 | Melanogenesis | 3.10E−04 | 1.00E−02 |
| 5 | ErbB signaling pathway | 4.70E−04 | 1.20E−02 |
| 6 | Vascular smooth muscle contraction | 4.80E−04 | 1.00E−02 |
| 7 | Phosphatidylinositol signaling system | 1.40E−03 | 2.50E−02 |
| 8 | Calcium signaling pathway | 1.50E−03 | 2.50E−02 |
| 9 | Adherens junction | 2.60E−03 | 3.70E−02 |
KEGG pathway enrichments were performed with the DAVID Functional Annotation Tool (http://david.abcc.ncifcrf.gov/) and Benjiamini adjusted p<0.05 was regarded as enriched.
KEGG pathways in which the common differentially methylated genes of WRRh Vs. XHh and WRRl Vs. XHl enriched.
| No. | Pathways | P value | Benjiamini |
| 1 | MAPK signaling pathway | 3.00E−04 | 3.80E−02 |
| 2 | Adherens junction | 4.10E−04 | 2.60E−02 |
| 3 | Focal adhesion | 4.50E−04 | 1.90E−02 |
| 4 | Melanogenesis | 5.60E−04 | 1.80E−02 |
| 5 | Tight junction | 1.20E−03 | 3.00E−02 |
| 6 | Phosphatidylinositol signaling system | 1.40E−03 | 2.90E−02 |
| 7 | Calcium signaling pathway | 1.80E−03 | 3.20E−02 |
| 8 | Vascular smooth muscle contraction | 2.00E−03 | 3.20E−02 |
KEGG pathway enrichments were performed with the DAVID Functional Annotation Tool (http://david.abcc.ncifcrf.gov/) and Benjiamini adjusted p<0.05 was regarded as enriched.
Differentially methylated genes shared by WRRh Vs. WRRl, XHh Vs. XHl, WRRh Vs. XHh, and WRRl Vs. XHl.
| No. | Gene | Description |
| 1 | ACTN1 | actinin, alpha 1 |
| 2 | AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) |
| 3 | BCL2 | B-cell CLL/lymphoma 2 |
| 4 | CACNA1B | calcium channel, voltage-dependent, N type, alpha 1B subunit |
| 5 | CACNA1D | calcium channel, voltage-dependent, L type, alpha 1D subunit |
| 6 | CACNA1H | calcium channel, voltage-dependent, T type, alpha 1H subunit |
| 7 | CACNA1I | calcium channel, voltage-dependent, T type, alpha 1I subunit |
| 8 | CACNA2D1 | calcium channel, voltage-dependent, alpha 2/delta subunit 1; similar to voltage-gated calcium channel alpha2/delta-1 subunit |
| 9 | CACNA2D3 | calcium channel, voltage-dependent, alpha 2/delta 3 subunit |
| 10 | CACNB2 | calcium channel, voltage-dependent, beta 2 subunit |
| 11 | CACNG2 | calcium channel, voltage-dependent, gamma subunit 2 |
| 12 | CAPN2 | calpain 2, (m/II) large subunit |
| 13 | COL5A2 | collagen, type V, alpha 2 |
| 14 | COL6A2 | collagen, type VI, alpha 2 |
| 15 | CREBBP | CREB binding protein (Rubinstein-Taybi syndrome) |
| 16 | CSNK2A1 | casein kinase 2, alpha 1 polypeptide |
| 17 | CTNNA2 | catenin (cadherin-associated protein), alpha 2 |
| 18 | CTNNA3 | catenin (cadherin-associated protein), alpha 3 |
| 19 | EP300 | E1A binding protein p300 |
| 20 | EVI1 | ecotropic viral integration site 1 |
| 21 | FARP2 | FERM, RhoGEF and pleckstrin domain protein 2 |
| 22 | FGF12 | fibroblast growth factor 12 |
| 23 | FGF14 | fibroblast growth factor 14 |
| 24 | FGF18 | fibroblast growth factor 18 |
| 25 | FGFR2 | fibroblast growth factor receptor 2 |
| 26 | FGFR3 | fibroblast growth factor receptor 3 |
| 27 | FLNB | filamin B, beta (actin binding protein 278) |
| 28 | FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
| 29 | GSK3B | glycogen synthase kinase 3 beta |
| 30 | HRAS | v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
| 31 | IGF1R | insulin-like growth factor 1 receptor |
| 32 | ITGA9 | integrin, alpha 9 |
| 33 | ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
| 34 | ITGB5 | integrin, beta 5 |
| 35 | KRAS | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
| 36 | LAMA3 | laminin, alpha 3 |
| 37 | LAMB3 | laminin, beta 3 |
| 38 | LMO7 | LIM domain 7 |
| 39 | LOC422316 | similar to receptor tyrosine kinase flk-1/VEGFR-2 |
| 40 | MAP2K4 | mitogen-activated protein kinase kinase 4 |
| 41 | MAP2K5 | mitogen-activated protein kinase kinase 5 |
| 42 | MAP3K3 | mitogen-activated protein kinase kinase kinase 3 |
| 43 | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 |
| 44 | MAP3K7 | mitogen-activated protein kinase kinase kinase 7 |
| 45 | MAP4K4 | mitogen-activated protein kinase kinase kinase kinase 4; similar to mitogen-activated protein kinase kinase kinase kinase 4 |
| 46 | MAPK14 | mitogen-activated protein kinase 14 |
| 47 | MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 |
| 48 | MAPKAPK5 | mitogen-activated protein kinase-activated protein kinase 5 |
| 49 | MKNK1 | MAP kinase interacting serine/threonine kinase 1 |
| 50 | NF1 | neurofibromin 1 |
| 51 | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
| 52 | PAK7 | p21(CDKN1A)-activated kinase 7 |
| 53 | PARD3 | par-3 partitioning defective 3 homolog (C. elegans) |
| 54 | PARVA | parvin, alpha |
| 55 | PARVB | parvin, beta |
| 56 | PDGFA | platelet-derived growth factor alpha polypeptide |
| 57 | PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide |
| 58 | PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (p55, gamma) |
| 59 | PIK3R5 | phosphoinositide-3-kinase, regulatory subunit 5, p101 |
| 60 | PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) |
| 61 | PPP1R12A | protein phosphatase 1, regulatory (inhibitor) subunit 12A |
| 62 | PPP2CB | protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform |
| 63 | PPP3CB | protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform |
| 64 | PRKCA | protein kinase C, alpha |
| 65 | PTK2 | PTK2 protein tyrosine kinase 2 |
| 66 | PTPRR | protein tyrosine phosphatase, receptor type, R |
| 67 | RELN | reelin |
| 68 | RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 |
| 69 | SOS2 | son of sevenless homolog 2 (Drosophila) |
| 70 | SSX2IP | synovial sarcoma, X breakpoint 2 interacting protein |
| 71 | TCF7 | transcription factor 7 (T-cell specific, HMG-box) |
| 72 | TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) |
| 73 | VAV3 | vav 3 oncogene |
| 74 | XIAP | X-linked inhibitor of apoptosis |
| 75 | YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 |